RTHP-32. PHASE II STUDY OF HYPO-FRACTIONATED ACCELERATED RADIOTHERAPY WITH CONCURRENT AND MAINTENANCE TEMOZOLOMIDE IN NEWLY DIAGNOSED GLIOBLASTOMA: COMPLIANCE AND EARLY CLINICAL OUTCOME (HyART)

INTRODUCTION: To compare hypo-fractionated (HyRT) with conventional fractionated radiotherapy (CRT) for good prognosis newly diagnosed patients with glioblastoma (GBM). METHODS: HyART, a Phase II trial randomly assigned newly diagnosed GBM patients 1:1 by computer generated randomization chart to Hy...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Mallick, Supriya, Haresh, Kunhi parambath, Gupta, Subhash, Sharma, Dayanand, Julka, Pramod, Rath, Goura Kishor
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2017
Assuntos:
Abstracts
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5692008/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.914
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados